
MSPEA leads acquisition of Korres
Morgan Stanley Private Equity Asia (MSPEA) and Profex, a Chinese skincare company, have agreed to pay €48.3m for a majority interest in Korres, a listed Greek specialist cosmetics manufacturer.
Nissos, an acquisition vehicle set up by MSPEA and Profex, will buy a 6.6% stake from the company's founder, Giorgos Korres, and 45.7% from other shareholders, according to a filing.
MSPEA and Profex will respectively own 56% and 14% of Nissos. Giorgos Korres and members of his family will exchange their remaining 30% interest in the company for an equal share in the acquisition vehicle.
Once these transactions have been completed, Nissos will hold more than 82% of Korres and launch a mandatory takeover offer for the entire company. The offer price will be €5.08 per share, valuing the entire business at approximately $69m. Korres's stock closed at €4.91 on December 27, the day the deal was announced.
MSPEA and Profex are expected to invest €10m to support the future expansion of Korres. Meanwhile, the company has entered into an exclusive licence-and-supply agreement with Profex covering mainland China, Hong Kong and Macau.
MSPEA is currently investing its fourth pan-regional fund, which closed on $1.7bn in 2014.
Recent activity includes the sale of Chinese convenience store chain Hi-24 to several strategic investors and a proposed $172m privatisation of Nasdaq-listed power-steering components supplier China Automotive Systems.
Company
Established in 1996, Korres develops products based on natural ingredients through cooperation with local farmers.
The company now has a portfolio of 400 herbal products that are distributed to 30 countries in Europe, the Middle East, Asia and North America. Sales came to €54.6m in 2016, up 0.1% year-on-year, while adjusted EBITDA was unchanged at €8.2m, and the net loss widened from €1.4m to €2.3m.
People
Korres – Giorgos Korres (chairman).
This article was originally published in unquote" sister publication AVCJ
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater